tiprankstipranks
Trending News
More News >
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market

Spyre Therapeutics (SYRE) Revenue

Compare
488 Followers

Spyre Therapeutics Revenue

Spyre Therapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, Spyre Therapeutics had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Revenue/Employee
$0
Employees
73
Market Cap
$2.69B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
-886.00K
Dec 31, 2023
886.00K-1.44M+38.04%
Dec 31, 2022
2.33M-16.41M+12.43%
Dec 31, 2021
18.74M-1,873,900,000.00%
Dec 31, 2020
Dec 31, 2019
-3.89M
Dec 31, 2018
3.89M-1.32M+74.70%
Dec 31, 2017
5.21M577.00K+112.47%
Dec 31, 2016
4.63M